FindTrial
Sign In

Correlation between the expression of Cathepsin H in lung adenocarcinoma and clinical prognosis and tumor invasion

Correlation between the expression of Cathepsin H in lung adenocarcinoma and clinical prognosis and tumor invasion

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400094072
Enrollment
Unknown
Registered
2024-12-17
Start date
2024-12-20
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung adenocarcinoma

Interventions

High expression of Cathepsin H:None
Low expression of Cathepsin H:None

Sponsors

The First Affiliated Hospital, Jinan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Pathologically-confirmed lung adenocarcinoma; 2.age over 18 years old;

Exclusion criteria

Exclusion criteria: 1.Pathological types other than adenocarcinoma, such as squamous cell carcinoma, small-cell lung cancer;

Design outcomes

Primary

MeasureTime frame
Expression of CTSH;—

Countries

China

Contacts

Public ContactLiao Hua

The First Affiliated Hospital, Jinan University

liaoh87@163.com+86 20 38688629

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026